Trait centric view

1. Trait name:	Dairy form
   Ontology terms:	VT:1000726

   154 genes are associated with this trait, with QTL/association found

   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45076;
   • ACSS3: Acyl-CoA synthetase short chain family member 3
     evidenced by: QTL:40768;
   • ACTE1: Actin epsilon 1
     evidenced by: QTL:53996;
   • ADAM10: ADAM metallopeptidase domain 10
     evidenced by: QTL:44748;
   • ADAM2: ADAM metallopeptidase domain 2
     evidenced by: QTL:53538;
   • ADCY3: Adenylate cyclase 3
     evidenced by: QTL:45543; QTL:45557;
   • ADCY5: Adenylate cyclase 5
     evidenced by: QTL:38478;
   • AKT3: AKT serine/threonine kinase 3
     evidenced by: QTL:48273;
   • ANXA4: Annexin A4
     evidenced by: QTL:45038;
   • AP3B1: Adaptor-related protein complex 3, beta 1 subunit
     evidenced by: QTL:44333;
   • APH1B: Aph-1 homolog B, gamma-secretase subunit
     evidenced by: QTL:44728;
   • ARHGAP10: Rho GTPase activating protein 10
     evidenced by: QTL:48693;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53314;
   • BCAS3: BCAS3 microtubule associated cell migration factor
     evidenced by: QTL:50025;
   • BCR: BCR activator of RhoGEF and GTPase
     evidenced by: QTL:49428;
   • BMP5: Bone morphogenetic protein 5
     evidenced by: QTL:51972;
   • BSND: Barttin CLCNK type accessory subunit beta
     evidenced by: QTL:40128;
   • BTBD11: BTB domain containing 11
     evidenced by: QTL:41131; QTL:41147;
   • C18H19ORF47: Chromosome 18 C19orf47 homolog
     evidenced by: QTL:49659;
   • C3H1ORF87: Chromosome 3 C1orf87 homolog
     evidenced by: QTL:40015;
   • C8B: Complement C8 beta chain
     evidenced by: QTL:40066;
   • CACHD1: Cache domain containing 1
     evidenced by: QTL:39955;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40607;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:44587; QTL:44601;
   • CC2D1A: Coiled-coil and C2 domain containing 1A
     evidenced by: QTL:42719;
   • CCDC141: Coiled-coil domain containing 141
     evidenced by: QTL:39046;
   • CGNL1: Cingulin like 1
     evidenced by: QTL:44768;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53727;
   • COBLL1: Cordon-bleu WH2 repeat protein like 1
     evidenced by: QTL:39231;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54587;
   • COL6A1: Collagen type VI alpha 1 chain
     evidenced by: QTL:38928;
   • CPA5: Carboxypeptidase A5
     evidenced by: QTL:40658;
   • CPQ: Carboxypeptidase Q
     evidenced by: QTL:47680;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:40826;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53758;
   • DAB1: DAB adaptor protein 1
     evidenced by: QTL:40057;
   • DCUN1D1: Defective in cullin neddylation 1 domain containing 1
     evidenced by: QTL:38489;
   • DHX36: DEAH-box helicase 36
     evidenced by: QTL:38696;
   • DOT1L: DOT1 like histone lysine methyltransferase
     evidenced by: QTL:42847;
   • DSCAM: DS cell adhesion molecule
     evidenced by: QTL:38918;
   • DTNA: Dystrobrevin alpha
     evidenced by: QTL:52354;
   • EIF2B3: Eukaryotic translation initiation factor 2B subunit gamma
     evidenced by: QTL:40185;
   • EPHB1: EPH receptor B1
     evidenced by: QTL:38837; QTL:38848; QTL:38860;
   • EXOC4: Exocyst complex component 4
     evidenced by: QTL:40672;
   • FAS: Fas (TNF receptor superfamily, member 6)
     evidenced by: QTL:52651;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51705; QTL:51718; QTL:51732;
   • FNDC3B: Fibronectin type III domain containing 3B
     evidenced by: QTL:38634;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51359;
   • FRMD6: FERM domain containing 6
     evidenced by: QTL:44720;
   • GALNT2: Polypeptide N-acetylgalactosaminyltransferase 2
     evidenced by: QTL:53643;
   • GANC: Glucosidase alpha, neutral C
     evidenced by: QTL:44573;
   • GPHN: Gephyrin
     evidenced by: QTL:44941;
   • GRIA3: Glutamate ionotropic receptor AMPA type subunit 3
     evidenced by: QTL:54158; QTL:54166; QTL:54183;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49678;
   • GTDC1: Glycosyltransferase like domain containing 1
     evidenced by: QTL:39432;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:52748; QTL:52759; QTL:52772;
   • IGSF5: Immunoglobulin superfamily member 5
     evidenced by: QTL:38906;
   • IL1RAPL2: Interleukin 1 receptor accessory protein-like 2
     evidenced by: QTL:54531;
   • KCNIP1: Potassium voltage-gated channel interacting protein 1
     evidenced by: QTL:50348;
   • KCTD2: Potassium channel tetramerization domain containing 2
     evidenced by: QTL:50148;
   • KHDRBS2: KH RNA binding domain containing, signal transduction associated 2
     evidenced by: QTL:51868;
   • KLHL1: Kelch like family member 1
     evidenced by: QTL:46310;
   • KMT2A: Lysine methyltransferase 2A
     evidenced by: QTL:47838;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42552;
   • LMO7: LIM domain 7
     evidenced by: QTL:46417;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:42207;
   • LRBA: LPS responsive beige-like anchor protein
     evidenced by: QTL:48671; QTL:48682;
   • MACROD2: MACRO domain containing 2
     evidenced by: QTL:43694;
   • MAOB: Monoamine oxidase B
     evidenced by: QTL:54913;
   • MAPKBP1: Mitogen-activated protein kinase binding protein 1
     evidenced by: QTL:44547;
   • MEF2C: Myocyte enhancer factor 2C
     evidenced by: QTL:43350;
   • MID1: Midline 1
     evidenced by: QTL:55494;
   • MINAR2: Membrane integral NOTCH2 associated receptor 2
     evidenced by: QTL:42891;
   • MND1: Meiotic nuclear divisions 1
     evidenced by: QTL:48580;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:52005;
   • MRC2: Mannose receptor C type 2
     evidenced by: QTL:49981;
   • MSGN1: Mesogenin 1
     evidenced by: QTL:45661;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40981;
   • MYH10: Myosin heavy chain 10
     evidenced by: QTL:215102;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:46532;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:38376; QTL:45721; QTL:45756;
   • NCOA1: Nuclear receptor coactivator 1
     evidenced by: QTL:45571;
   • NCSTN: Nicastrin
     evidenced by: QTL:39712;
   • NDP: Norrin cystine knot growth factor NDP
     evidenced by: QTL:54902;
   • NDUFAF1: NADH:ubiquinone oxidoreductase complex assembly factor 1
     evidenced by: QTL:44515;
   • NFIX: Nuclear factor I X
     evidenced by: QTL:42750; QTL:42763;
   • NHS: NHS actin remodeling regulator
     evidenced by: QTL:55239;
   • NIN: Ninein
     evidenced by: QTL:44713;
   • NPFFR2: Neuropeptide FF receptor 2
     evidenced by: QTL:167548;
   • NPR3: Natriuretic peptide receptor 3
     evidenced by: QTL:50771;
   • NPSR1: Neuropeptide S receptor 1
     evidenced by: QTL:40400;
   • NRF1: Nuclear respiratory factor 1
     evidenced by: QTL:40648;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53818;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42572;
   • OAZ1: Ornithine decarboxylase antizyme 1
     evidenced by: QTL:42835;
   • OSBPL10: Oxysterol binding protein like 10
     evidenced by: QTL:51557;
   • OSR1: Odd-skipped related transcription factor 1
     evidenced by: QTL:45625;
   • PAK5: P21 (RAC1) activated kinase 5
     evidenced by: QTL:46621;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:40807;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39727;
   • PHF2: PHD finger protein 2
     evidenced by: QTL:43715;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55212;
   • PLA2G4F: Phospholipase A2 group IVF
     evidenced by: QTL:44558;
   • PLCD3: Phospholipase C delta 3
     evidenced by: QTL:50054;
   • PRICKLE1: Prickle planar cell polarity protein 1
     evidenced by: QTL:40880;
   • PRKG1: Protein kinase, cGMP-dependent, type I
     evidenced by: QTL:52643;
   • PRNP: Prion protein
     evidenced by: QTL:1676;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:46100;
   • RAB15: RAB15, member RAS oncogene family
     evidenced by: QTL:44927;
   • RAD51: RAD51 recombinase
     evidenced by: QTL:44469;
   • RASA3: RAS p21 protein activator 3
     evidenced by: QTL:46576;
   • RBMS1: RNA binding motif single stranded interacting protein 1
     evidenced by: QTL:39370;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41094;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45904;
   • RPAP1: RNA polymerase II associated protein 1
     evidenced by: QTL:44535;
   • RSPO2: R-spondin 2
     evidenced by: QTL:47651;
   • RTF1: RTF1 homolog, Paf1/RNA polymerase II complex component
     evidenced by: QTL:44525;
   • RUNX1: RUNX family transcription factor 1
     evidenced by: QTL:38955;
   • SCARF1: Scavenger receptor class F member 1
     evidenced by: QTL:50038;
   • SCEL: Sciellin
     evidenced by: QTL:28110;
   • SEC22A: SEC22 homolog A, vesicle trafficking protein
     evidenced by: QTL:38470;
   • SLC10A7: Solute carrier family 10 member 7
     evidenced by: QTL:48706;
   • SLC25A12: Solute carrier family 25 member 12
     evidenced by: QTL:39075;
   • SLC25A13: Solute carrier family 25 member 13
     evidenced by: QTL:40331;
   • SLC35D2: Solute carrier family 35 member D2
     evidenced by: QTL:43706;
   • SLC6A1: Solute carrier family 6 member 1
     evidenced by: QTL:51832;
   • SLC6A9: Solute carrier family 6 member 9
     evidenced by: QTL:47025;
   • SMOC1: SPARC related modular calcium binding 1
     evidenced by: QTL:44957;
   • SPRED2: Sprouty related EVH1 domain containing 2
     evidenced by: QTL:45494;
   • SREBF2: Sterol regulatory element binding transcription factor 2
     evidenced by: QTL:41614;
   • SRP68: Signal recognition particle 68
     evidenced by: QTL:50099;
   • SYN2: Synapsin II
     evidenced by: QTL:51851;
   • SYN3: Synapsin III
     evidenced by: QTL:41179;
   • SYTL5: Synaptotagmin like 5
     evidenced by: QTL:54980;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39339;
   • TEN1: TEN1 subunit of CST complex
     evidenced by: QTL:50114;
   • TENM2: Teneurin transmembrane protein 2
     evidenced by: QTL:43303;
   • TIMP2: TIMP metallopeptidase inhibitor 2
     evidenced by: QTL:50072;
   • TLN2: Talin 2
     evidenced by: QTL:44739;
   • TMED8: Transmembrane p24 trafficking protein family member 8
     evidenced by: QTL:44979;
   • TMEM61: Transmembrane protein 61
     evidenced by: QTL:40137;
   • TMEM87B: Transmembrane protein 87B
     evidenced by: QTL:45048;
   • TPCN1: Two pore segment channel 1
     evidenced by: QTL:49385;
   • TRABD2B: TraB domain containing 2B
     evidenced by: QTL:40165;
   • TRAF5: TNF receptor associated factor 5
     evidenced by: QTL:48477;
   • TTYH2: Tweety family member 2
     evidenced by: QTL:50192;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53601; QTL:53613;
   • UBR1: Ubiquitin protein ligase E3 component n-recognin 1
     evidenced by: QTL:44617; QTL:44631;
   • UNC5D: Unc-5 netrin receptor D
     evidenced by: QTL:53508;
   • USP13: Ubiquitin specific peptidase 13
     evidenced by: QTL:38578;
   • XRCC4: X-ray repair cross complementing 4
     evidenced by: QTL:43315; QTL:43323;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:52174;
   • ZNF280D: Zinc finger protein 280D
     evidenced by: QTL:44777;
   • ZNF407: Zinc finger protein 407
     evidenced by: QTL:52263;
   327 correlations are found involving Dairy form